Slide 1: Q1 2023 Update
Q1 2023 Update May 2023 Innovation through formulation
Slide 2: Agenda
Agenda 1• Key developments & business update 2• Financial performance 3• Outlook 4• Q&A 2 © 2023 Azelis group. All rights reserved
Slide 3: Disclaimer
Disclaimer This document may contain statement relevant to Azelis Group NV (the “Company”) and/or its affiliated companies (collectively “Azelis” or the “Azelis Group”) which are not historical facts and are hereby identified as “forward-looking statements”. Such forward looking statements, include,
Slide 4: Key developments & business update Q1 2023
Key developments & business update Q1 2023 4 © 2023 Azelis group. All rights reserved
Slide 5: Key developments Q1 2023
Key developments Q1 2023 Diverse footprint Resilient margins Progress on initiatives Balance Sheet • 12.0% total revenue • Organic growth in gross • Continued investments in • 135.2% increase in Free growth versus 59.4% in profit and adjusted digital strategy Cash Flow (€ 136.1m) the prior year EBIT
Slide 6: Business update: Resilience
Business update: Resilience Organic revenue: -1.2% in Q1 2023 • Life Sciences: Sustained momentum in most end markets across EMEA and APAC, even compared to strong Q1 2022. The Americas continued to be impacted by destocking in Flavors & Fragrances. • Industrial chemicals: Stable demand and prices a
Slide 7: Financial performance Q1 2023
Financial performance Q1 2023 7 © 2023 Azelis group. All rights reserved
Slide 8: Headline P&L Q1 2023
Headline P&L Q1 2023 Azelis Group Highlights Q1 2023 Q1 2022 Reported Change Constant Currency (EUR m) Life Sciences 669.0 592.8 12.9% 12.9% Industrial Chemicals 423.8 382.5 10.8% 10.6% Group Revenue 1,092.8 975.3 12.0% 12.0% Gross Profit 265.8 235.9 12.7% 12.3% Gross Profit Margin 24.3% 24.2% 13 bp
Slide 9: Headline growth Q1 2023
Headline growth Q1 2023 Azelis Performance F/X M&A Growth Organic Total Q1 2023 Q1 2022 (EUR m) Translation Contribution Growth Growth EMEA 501.0 450.5 -2.1% 8.9% 4.4% 11.2% Americas 358.4 366.5 3.7% 7.5% -13.4% -2.2% Asia Pacific 233.5 158.3 -2.0% 38.5% 11.0% 47.5% Group Revenue 1,092.8 975.3 0.1%
Slide 10: Regional financial update
Regional financial update EMEA Americas Asia Pacific EBITA 14.5% EBITA EBITA margin 13.3% +11.2% margin 13.6% 13.6% margin 9.2% € 501 8.6% € 451 -2.2% € 366 € 358 +47.5% € 233 Revenue Revenue Revenue € 158 55.9% 53.7% Conversion Conversion Conversion 53.9% 47.6% margin margin 53.5% margin 43.2% Q1 2
Slide 11: Working Capital
Working Capital Working Capital Evolution of NWC* Receivables Inventory Payables NWC/ 10.9% 11.1% 15.3% 13.8% 14.6% 14.7% Revenue 550 656 628 467 262 268 443 502 516 376 200 218 -227 -235 -369 -463 -467 -513 2019 2020 2021 2022 Q1 2022 Q1 2023 DSO 34 35 44 37 46 42 Jan Feb Mar Apr May Jun Jul Aug Se
Slide 12: Outlook
Outlook 12 © 2023 Azelis group. All rights reserved
Slide 13: Outlook
Outlook Our strategy of driving growth is underpinned by a constantly strengthening lateral value chain, supported by continuous investments in innovation capabilities and digitalization, as well as a commitment to sustainability to create long-term value. In line with this, we are confident that we
Slide 14: Q1 2023 Update Q&A
Q1 2023 Update Q&A Contact Investor Relations investor-relations@azelis.com +32 3 613 01 27 14 © 2023 Azelis group. All rights reserved